Long-Term Anticoagulation in the Extreme Elderly with the Newer Antithrombotics: Safe or Sorry?

@inproceedings{Chiong2013LongTermAI,
  title={Long-Term Anticoagulation in the Extreme Elderly with the Newer Antithrombotics: Safe or Sorry?},
  author={Jun Ratunil Chiong and Rebecca J. Cheung},
  booktitle={Korean circulation journal},
  year={2013}
}
BACKGROUND AND OBJECTIVES The prevalence of atrial fibrillation (AF) doubles in the extreme elderly and is higher than in the rest of the population. Warfarin therapy to prevent thromboembolic events secondary to AF is often underutilized and under-prescribed in this subgroup, due to the fear of bleeding and other complications. Newer oral anticoagulants such as rivaroxaban and dabigatran offer alternative therapeutic options for the extreme elderly. We review the clinical trial data of these… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 5 times over the past 90 days. VIEW TWEETS

References

Publications referenced by this paper.
Showing 1-10 of 29 references

How can we avoid a stroke crisis in the Asia-Pacific region? Working group report: stroke prevention in patients with atrial fibrillation [Internet

  • S Goto, G Hankey, MT Hills
  • Chameleon Communications International;
  • 2011

Similar Papers

Loading similar papers…